Učitavanje...
(90)Y-DOTATOC Dosimetry–Based Personalized Peptide Receptor Radionuclide Therapy
Pretherapy PET with (86)Y-DOTATOC is considered the ideal dosimetry protocol for (90)Y-DOTATOC therapy; however, its cost, limited availability, and need for infusion of amino acids to mimic the therapy administration limit its use in the clinical setting. The goal of this study was to develop a dos...
Spremljeno u:
| Izdano u: | J Nucl Med |
|---|---|
| Glavni autori: | , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Society of Nuclear Medicine
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6225542/ https://ncbi.nlm.nih.gov/pubmed/29523629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.202903 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|